Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Early Jejunostomy Nutrition Minimizes Time to Chemotherapy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2013 by Jinling Hospital, China.
Recruitment status was  Not yet recruiting
National Natural Science Foundation of China
Information provided by (Responsible Party):
Qi Mao, Jinling Hospital, China Identifier:
First received: January 10, 2013
Last updated: NA
Last verified: January 2013
History: No changes posted

January 10, 2013
January 10, 2013
April 2013
April 2014   (final data collection date for primary outcome measure)
The time to the first adjuvant chemotherapy [ Time Frame: 30 days after operation ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
  • Overall morbidity rate of jejunostomy nutrition [ Time Frame: 60 days after operation ] [ Designated as safety issue: Yes ]
  • Overall morbidity rate of early oral nutrition [ Time Frame: 60 days after operation ] [ Designated as safety issue: Yes ]
  • Postoperative mortality rate [ Time Frame: 60 days after operation ] [ Designated as safety issue: Yes ]
  • Time to tolerate EJN/EON [ Time Frame: 30 days after operation ] [ Designated as safety issue: No ]
  • Time to full oral nutrition [ Time Frame: 30 days after operation ] [ Designated as safety issue: No ]
  • Body composition [ Time Frame: 10 days after operation ] [ Designated as safety issue: No ]
  • Energy metabolism [ Time Frame: 10 days after operation ] [ Designated as safety issue: No ]
  • Postoperative hospital stay length [ Time Frame: 60 days after operation ] [ Designated as safety issue: No ]
  • Rehospitalization rate [ Time Frame: 30 days after discharge ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
Early Jejunostomy Nutrition Minimizes Time to Chemotherapy
Fast-track Surgery Recovery Program With Early Jejunostomy Nutrition Protocol Minimizes Time to Adjuvant Chemotherapy in Patients Undergoing Laparoscopic Gastrectomy for Gastric Cancer

Adjuvant chemotherapy (AC) for gastric cancer is known to improve prognosis, and longer time to AC is associated with worse survival. However, most clinical trials mandate that AC is still to commence within 6 to 8 weeks after surgery consideration for malnutrition, postoperative complications and intolerance of AC. Placement of jejunostomy nutrition tube for enteral nutrition is a common component of these procedures, as a result of superior postoperative organ function, decreased infection rates, and a greater likelihood to complete AC with enteral nutritional support.

Fast-track surgery (FTS) recovery program focuses on enhancing recovery and reducing morbidity. Introduction of FTS concepts are safe, feasible, and can achieve shorter hospital stays and reduced costs. Early postoperative enteral nutrition combined with FTS results in reductions in total complications compared with traditional postoperative feeding practices and does not negatively affect outcomes. However, the benefit of jejunostomy nutrition tube routine placement and combination with FTS is still being debated. Besides, there remains some controversy over the optimal combination of nutrients and duration and timing and routes of feed administration.

The aim of this study was to determine whether FTS with early jejunostomy nutrition (EJN) following laparoscopic gastrectomy for gastric cancer improved postoperative recovery and minimizes time to AC when compared with FTS with early oral nutrition (EON).

Not Provided
Phase 4
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
  • Gastric Cancer
  • Laparoscopic Surgery
  • Chemotherapy
  • Procedure: Jejunostomy
    Routine placement of jejunostomy tube following laparoscopic gastrectomy for gastric cancer. Immediately drip 37°C saline 20 ml/h and exchange to drip 37°C enteral nutrition fluid 20 ml/h at postoperative 6 h via jejunostomy tube
  • Other: Early oral nutrition
    Free oral nutrition as tolerance allows on POD 1.
  • Experimental: Early jejunostomy nutrition
    Intervention: Procedure: Jejunostomy
  • Active Comparator: Early oral nutrition
    Intervention: Other: Early oral nutrition

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Not yet recruiting
June 2014
April 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Primary gastric cancer
  • R0 resection

Exclusion Criteria:

  • Metastatic tumor
  • Locally unresectable tumor
  • Previous gastric/enteral resection
  • Age under 18 years or over 70 years
  • Preoperative complete parenteral or enteral nutrition
  • Neo-adjuvant chemotherapy
  • Severe malnutrition
  • Lack of the patient's consent for the trial participation, jejunostomy tube insertion or epidural analgesia
18 Years to 70 Years   (Adult, Senior)
Contact: Qi Mao, MD/PhD +862580860961
Contact: Yousheng Li, MD/PhD +862580860137
Not Provided
Not Provided
Qi Mao, Jinling Hospital, China
Jinling Hospital, China
National Natural Science Foundation of China
Principal Investigator: Qi Mao, MD/PhD Jinling Hospital, China
Jinling Hospital, China
January 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP